Global Molecular Cytogenetics Strategic Business Report 2015-2022 - Research and Markets

Jul 04, 2016, 07:10 ET from Research and Markets

DUBLIN, July 4, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Molecular Cytogenetics - Global Strategic Business Report" report to their offering. 
     (Logo: )

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. 

This report analyzes the worldwide markets for Molecular Cytogenetics in US$ Thousand by the following Technologies: Fluorescence In Situ Hybridization, Array-based Technology. 

The report profiles 27 companies including many key and niche players such as 

  • Abbott Molecular, Inc. (US)
  • Agilent Technologies, Inc. (US)
  • Affymetrix, Inc. (US)
  • Applied Spectral Imaging (US)
  • Biological Industries (Israel)
  • Bio-Rad Laboratories, Inc. (US)
  • CytoTest, Inc. (US)
  • Cytognomix, Inc. (Canada)
  • Illumina, Inc. (US)
  • Leica Biosystems Nussloch GmbH (Germany)
  • Oxford Gene Technology (UK)
  • PerkinElmer, Inc. (US)
  • Roche NimbleGen, Inc. (US)
  • SciGene Corporation (US)
  • Thermo Fisher Scientific, Inc. (US)

Key Topics Covered:


  • Advanced Molecular Biology Techniques Broaden the Scope of Cytogenetics
  • Major Growth Drivers
  • Market Outlook
  • Nucleic Acid Diagnostics Market
  • An Overview
  • Molecular Cytogenetics Greatly Benefit Cancer Prognosis
  • Diverse Applications of FISH Technology in Oncology
  • Opportunity Indicators: Global Cancer Incidence on the Rise
  • Increasing Significance of Cytogenetic Analysis in Genetic Disease Diagnosis
  • Array-based Technologies to Drive Significant Market Growth
  • Transition from FISH to Array Based Technologies: A Major Trend
  • Array-based CGH to Emerge as First Line Test for Clinical Diagnosis of Chromosomal Anomalies
  • Molecular Cytogenetics Find Increasing Penetration in Clinical Pathological Testing
  • Enhanced AP LIS a Must to Keep Pace with Advancing Molecular Cytogenetic Testing
  • Impact of Shifting Focus of Biopharmaceuticals from Research to Development on Microarray Technology
  • Next-Gen Sequencing to Challenge Microarray Technology in the Distant Future
  • Technological Innovations Set to Drive the Market
  • Role of Molecular Cytogenetics in Personalized Medicine
  • Improving Healthcare Expenditure Turbo Charges Demand



  • NeoGenomics Introduces NeoSITE Cervical assay to FISH Testing Menu
  • Oxford Gene Technology Expands Cytocell FISH Probe Portfolio
  • Applied Spectral Imaging Receives Approval for GenASIs HiPath Platform
  • Agilent Technologies Introduces OneSeq
  • Leica Biosystems and Affymetrix Launch ViewRNA eZ Assays on BOND RX Platform
  • Affymetrix and BioDiscovery Launch Cancer Research Software
  • AKESOgen Launches Cytogenomics Microarray Test
  • Oxford Gene Technology Launches CytoSure Consortium Cancer + SNP array


  • Eurofins Scientific to Acquire Stake in Emory Genetics Laboratory
  • ESPERITE Acquires Inkaryo
  • Medivo Collaborates with NeoGenomics for Data Analytics
  • Affymetrix Enters into Agreement with CollabRx
  • Thermo Fisher Scientific Completes Acquisition of Life Technologies
  • Applied Spectral Imaging Signs Distribution Partnership with Biocare
  • Applied Spectral Imaging and BioDot Enter Into Marketing Agreement
  • Cancer Genetics Italia Enters into Distribution Agreement with Nikon Instruments S.p.A.
  • Applied Spectral Imaging Enters Into Agreement with WaveSense
  • Oxford Gene Technology Signs License Agreement with CCMC



Total Companies Profiled: 27 (including Divisions/Subsidiaries 28) 

  • The United States (20)
  • Canada (1)
  • Europe (6)
  • - Germany (2)
  • - The United Kingdom (1)
  • - Rest of Europe (3)
  • Asia-Pacific (Excluding Japan) (1)

For more information visit

Media Contact: 
Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets